Closed
Source verified April 27, 2026
Innovation Seed Grant
Seed funding for innovative Angelman syndrome research
Funding available
$ 10,000 - $ 50,000
Deadline
Open continuously
Location
Canada
Overview
This program provides seed funding of $10,000 to $50,000 for innovative Angelman syndrome research. It supports proof-of-concept studies, early-stage feasibility work, and high-risk, high-reward projects focused on treatment strategies, therapeutic targets, and biomarker discovery.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 50,000 $
- Minimum amount : 10,000 $
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- People with disabilities
- Academia / students
Revenue structures
- 100% donations / grants
Scope
- National
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Proof-of-concept research on Angelman syndrome
- Early-stage feasibility studies
- Research on new treatment strategies
- Therapeutic target discovery and biomarker identification
Documents Needed
- Letter of Intent
- Research hypotheses and specific aims
- Lay summary
- Detailed budget
- Biosketch of the PI and collaborators
Official resources
Application form
Eligibility
Who is eligible?
- Individual researchers
- Multidisciplinary research teams
- Academic institutions
- Industry scientific teams
Who is not eligible
- Organizations that do not have nonprofit status, except in rare cases specifically allowed by the program
Eligible expenses
- Reagents and services, including gene chips, chemical libraries, cell lines, and animal model lines
- Specialized services such as sequencing, proteomics, metabolomics, mass spectrometry, antibody production, and drug or chemical manufacturing
- Specialized equipment or software for specific projects
- Personnel salaries and fringe benefits, up to 20% of requested funds
Ineligible Costs and Activities
- Indirect costs
- General office supplies and equipment
- Bridging funds to cover gaps in grant funding
Eligible geographic areas
- United States
How to apply
- Step 1: Prepare the Letter of Intent
- Draft the one-page Letter of Intent.
- Include hypotheses and specific aims.
- Add a lay summary.
- Attach the detailed budget and biosketch.
- Step 2: Submit Online
- Upload the application materials electronically through the ProposalCentral link.
- Submit the application on a rolling basis.
- Step 3: Follow Up if Needed
- Contact FAST by email with questions about the application process.
Processing and Agreement
- Applications are reviewed on a rolling basis.
- Recipients must submit a final written and financial report after the project ends.
- FAST reviews progress with the Scientific Panel after report submission.
- Research using human or animal subjects requires the relevant institutional approvals before funds or activities proceed.
Additional information
- Applications are reviewed on a rolling basis.
- A final report is required within 60 days after project end.
- Human subjects research requires IRB approval before funds are released.
- Animal studies require IACUC approval before animal work begins.
Contacts
Frequently Asked Questions about the Innovation Seed Grant Program
What is the Innovation Seed Grant?
This program provides seed funding of $10,000 to $50,000 for innovative Angelman syndrome research. It supports proof-of-concept studies, early-stage feasibility work, and high-risk, high-reward projects focused on treatment strategies, therapeutic targets, and biomarker discovery.
How much funding can be received?
Innovation Seed Grant Funds up to $50,000 of admissible expenses.
Who is eligible for the Innovation Seed Grant program?
To be eligible for the Innovation Seed Grant program, you must:
Research focused on Angelman syndrome
Proof-of-concept or early-stage work
Researchers, teams, or collaborations
What expenses are eligible under Innovation Seed Grant?
Proof-of-concept research on Angelman syndrome
Early-stage feasibility studies
Research on new treatment strategies
Therapeutic target discovery and biomarker identification
Who can I contact for more information about the Innovation Seed Grant?
You can contact Foundation for Angelman Syndrome Therapeutics (FAST) by email at science@cureangelman.org.
Where is the Innovation Seed Grant available?
The Innovation Seed Grant program is available across Canada.
Is the Innovation Seed Grant a grant, loan, or tax credit?
Innovation Seed Grant is a Researchers And Facilities